Assertion: metastatic melanoma | /r/CapableOf | harbor c-kit mutation
Facets:
Source sentences:
text: Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.